Lung Cancer
ASCO 2022 Daily Round-Ups: Day 1
Catch up on our highlights from Day 1 of ASCO 2022! We spoke to Alexander Spira, Jia Luo, Paolo…
Date: 4th June 2022
Updates in radiation oncology from ESTRO 2022
This year’s European Society for Radiotherapy and Oncology (ESTRO) annual congress took place in Copenhagen, Denmark, from 6-10 May 2022,…
Date: 27th May 2022
Lung Cancer Screening: Current state and future directions
Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly…
Date: 1st April 2022
BTOG 2022: Highlights in lung cancer
For patients with lung cancer, surgical resection is a treatment option and perioperative management is imperative to improve surgical outcomes….
Date: 11th February 2022
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC
The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…
Date: 25th November 2021
ISLB 2021: Current standards and future directions for liquid biopsy
Liquid biopsy is an exciting field, with many promising advances in recent years. In this podcast, we cover a range…
Date: 12th November 2021
The Lung Cancer Sessions: Highlights from ASCO 2021
Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer…
Date: 7th October 2021
ASCO 2021: Immunotherapy updates in lung cancer
Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune…
Date: 4th August 2021
The Lung Cancer Sessions: Highlights from BTOG 2021
VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented…
Date: 22nd June 2021
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK…
Date: 12th May 2021
The Lung Cancer Sessions: highlights from IASLC WCLC
VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights…
Date: 18th February 2021
Updates in non-small cell lung cancer from ESMO
Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung…
Date: 3rd November 2020
